Effect of beta-blocker dose on the prognosis in chronic heart failure patients depending on the presence of atrial fibrillation. Data from FAR NHL (FARmacology and NeuroHumoraL activation) registry.

Back

ESC Premium Access

Effect of beta-blocker dose on the prognosis in chronic heart failure patients depending on the presence of atrial fibrillation. Data from FAR NHL (FARmacology and NeuroHumoraL activation) registry.

Session: New treatment studies in heart failure

Topic: Pharmacotherapy

Speaker: Assistant Professor K. Labr (Brno, CZ)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Assistant Professor Karel Labr

St. Anne University Hospital Brno (FNUSA), Brno (Czechia)

0 follower

8 more presentations in this session

Sequential nephron blockade with diuretics improves diastolic dysfunction in patients with resistant hypertension, a substudy a the PHARES trial

Speaker: Doctor D. Fouassier (Paris, FR)

Inhaled iloprost, exercise hemodynamics, and ventricular performance in heart failure with preserved ejection fraction

Speaker: Doctor J. Cheng (Taipei, TW)

Drug effect of luseogliflozin and voglibose on heart failure with preserved ejection fraction in diabetic patients: a multicenter randomized-controlled trial

Speaker: Doctor H. Kihara (Asahikawa, JP)

Diuretic and renal effects of spironolactone and heart failure hospitalizations: A TOPCAT Americas analysis

Speaker: Associate Professor A. Kalogeropoulos (Stony Brook, US)

Access

Use of phenomapping to determine response of treatment by sacubitril/valsartan in patients with heart failure with reduced ejection fraction

Speaker: Mr M. Godet (Rouen, FR)

Access the full session

New treatment studies in heart failure

Speakers: Assistant Professor K. Labr, Doctor D. Fouassier, Doctor J. Cheng, Doctor H. Kihara, Associate Professor A. Kalogeropoulos...

Access

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources